{
    "Trade/Device Name(s)": [
        "TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge",
        "TEG\u00ae 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge",
        "TEG\u00ae 6s analyzer",
        "TEG\u00ae 6s Assay Cartridges"
    ],
    "Submitter Information": "Haemonetics Corporation",
    "510(k) Number": "K251024",
    "Predicate Device Reference 510(k) Number(s)": [
        "K243858"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JPA"
    ],
    "Summary Letter Date": "April 30, 2025",
    "Summary Letter Received Date": "April 2, 2025",
    "Submission Date": "March 31, 2025",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose System For In Vitro Coagulation Studies"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology",
        "POCT"
    ],
    "Analyte(s)": [
        "Clotting Time (R)",
        "Speed of Clot Formation (K)",
        "Alpha angle",
        "Maximum Clot Strength (MA)",
        "Estimated Functional Fibrinogen Level (FLEV)",
        "Heparin effect"
    ],
    "Specimen Type(s)": [
        "Citrated whole blood",
        "3.2% citrated whole blood",
        "Venous whole blood",
        "Arterial whole blood"
    ],
    "Specimen Container(s)": [
        "3.2% sodium citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "TEG 6s Hemostasis analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Optical detection",
        "Thromboelastography",
        "Microfluidic cartridge system",
        "Piezoelectric actuator vibration"
    ],
    "Methodologies": [
        "Measurement of viscoelastic properties",
        "Fast Fourier Transform (FFT) of meniscus motion data",
        "Non-contact optical measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Assay Cartridge",
        "System",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for Haemonetics TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge for semi-quantitative assessment of coagulation in citrated whole blood using thromboelastography.",
    "Indications for Use Summary": "Provides semi-quantitative indications of hemostasis state from citrated whole blood in adult patients, including assessments of coagulation for cardiovascular surgery and cardiology procedures, usable in the laboratory or point-of-care.",
    "fda_folder": "Hematology"
}